On November 21, Gelonghui reported that cathay biotech inc. (688065.SH) stated on the investor interaction platform that currently, the bio-based polyamide continuous fiber composite materials developed by the company have begun sample production and validation in the fields of new energy fund, modern construction, and logistics. Based on the cost-performance advantages and market potential of these bio-based new materials, the company has conducted business connections with multiple subsidiaries and joint ventures of China Merchants Group, and several pilot projects are underway.
凯赛生物(688065.SH)：开发的生物基聚酰胺连续纤维复合材料已在新能源、现代建筑、交运物流等领域开始样品试制和验证
Cathay Biotech Inc. (688065.SH): The developed biobased polyamide continuous fiber composite materials have started sample trial production and verification in the new energy, modern construction, transportation logistics, and other fields.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated